Skip to main content
. 2019 Oct 14;2019(10):CD001908. doi: 10.1002/14651858.CD001908.pub4

Comparison 2. Tiagabine versus topiramate.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 50% or greater reduction in seizure frequency (ITT) 1 41 Risk Ratio (M‐H, Fixed, 95% CI) 0.54 [0.19, 1.58]
2 Treatment withdrawal (ITT) 1 41 Risk Ratio (M‐H, Fixed, 95% CI) 1.43 [0.74, 2.74]